Select Page
At the guidance of national, state, and local public health authorities, we have decided to postpone the 25th annual Southwest Prostate Cancer Symposium. The new dates for this conference will be December 10-12, 2020. If you have already registered for the conference and plan to attend on the new dates, you are all set and don’t need to change anything.
If you have any other questions, feel free to contact us with any questions at meetings@grandroundsinurology.com.
25th Annual Southwest Prostate Cancer Symposium
The Westin Kierland Resort & Spa
Scottsdale, AZ
December 10-12, 2020
Chaired by Nelson N. Stone, MD, the Southwest Prostate Cancer Symposium™ has been held in Scottsdale, AZ, for 24 years. This multi-day conference is intended for urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in the treatment of prostate cancer. It will educate the attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices.
Educational Goals
The goal of this educational program is to equip urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in prostate cancer care with the up-to-date clinical knowledge and tools they need to best treat their patients. The program aims to provide a technical update on all aspects of diagnosis and treatment of localized and advanced disease.
This program also offers training sessions for healthcare professionals to become proficient in imaging, scanning, and prostate cancer treatment-related devices on site.
Program Director
Nelson N. Stone, MD
Professor of Urology and Radiation Oncology
Icahn School of Medicine at Mount Sinai
Founder and Chief Medical Officer
3D Biopsy, Inc.
New York, New York
SPCS 2020 SPONSORS
PLATINUM LEVEL SUPPORT
Astellas Pharma US and Pfizer Oncology
Janssen Biotech
SILVER LEVEL SUPPORT
Ferring Pharmaceuticals
Sun Pharma
Carden Jennings Publishing is closely tracking updates from the Centers for Disease Control and Prevention on the novel coronavirus (COVID-19). The CDC reports that most people in the United States have little immediate risk of exposure at this time, and we continue to move forward with our plans to deliver an outstanding conference. The health of the attendees of our Grand Rounds in Urology conferences is a top priority, so we will continue to monitor the situation and provide updates as needed.